Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

Launched by UNIVERSITY OF EDINBURGH · Mar 14, 2024

Keywords

ClinConnect Summary

The ORACLE study is a clinical trial designed to help patients who may be experiencing angina, which is chest pain caused by reduced blood flow to the heart. The goal is to quickly assess the risk of heart problems for these patients within one day of their referral to a specialist clinic. Participants will be asked to complete a digital questionnaire about their health and symptoms from home. They will also undergo a standard heart test called an ECG, which records the heart's electrical activity, and will use a special device to take their own ECG. Additionally, a blood test will measure a specific protein that indicates heart stress.

To be eligible for this study, participants need to be over 30 years old and have been referred to the clinic for possible new or worsening angina. However, individuals who cannot give consent, have participated in the study before, or have had a heart attack in the last three months cannot join. By taking part in this study, individuals will be categorized as low, intermediate, or high risk for future heart issues, which can help guide their treatment moving forward.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • \>30 years of age
• • Referral to the rapid access chest pain clinic with possible new onset or worsening angina
• Exclusion Criteria:
• • Inability to give informed consent.
• • Previous recruitment to the study.
• • Acute coronary syndrome within 3 months.